What is William Blair's Estimate for InnovAge Q2 Earnings?

Key Points

• William Blair estimates InnovAge's Q2 2026 earnings at $0.04 per share, with full-year earnings expected to reach $0.15 per share.
• InnovAge's recent earnings report indicated a loss of ($0.01) per share, better than the consensus estimate of ($0.02).
• The company's stock has a market capitalization of $626.66 million and has shown a 52-week range between $2.60 and $6.69.

InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Research analysts at William Blair issued their Q2 2026 earnings per share estimates for InnovAge in a report released on Wednesday, September 10th. William Blair analyst J. Haase anticipates that the company will post earnings of $0.04 per share for the quarter. The consensus estimate for InnovAge's current full-year earnings is ($0.12) per share. William Blair also issued estimates for InnovAge's Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.07 EPS, FY2026 earnings at $0.15 EPS and FY2027 earnings at $0.23 EPS.

InnovAge Stock Performance

Shares of INNV traded up $0.43 during trading on Friday, reaching $4.98. 80,491 shares of the company traded hands, compared to its average volume of 27,170. The stock has a 50-day simple moving average of $3.82 and a 200-day simple moving average of $3.59. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.07 and a quick ratio of 1.07. InnovAge has a twelve month low of $2.60 and a twelve month high of $6.69.

InnovAge (NASDAQ:INNV - Get Free Report) last issued its quarterly earnings data on Tuesday, September 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $221.42 million during the quarter, compared to the consensus estimate of $219.80 million. InnovAge had a negative return on equity of 12.02% and a negative net margin of 3.55%. InnovAge has set its FY 2026 guidance at EPS.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in INNV. Barclays PLC grew its holdings in shares of InnovAge by 13.6% in the fourth quarter. Barclays PLC now owns 29,099 shares of the company's stock valued at $115,000 after purchasing an additional 3,485 shares in the last quarter. Jane Street Group LLC boosted its position in InnovAge by 230.6% in the 4th quarter. Jane Street Group LLC now owns 39,398 shares of the company's stock valued at $155,000 after buying an additional 27,481 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of InnovAge by 2.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 164,322 shares of the company's stock worth $490,000 after acquiring an additional 4,535 shares in the last quarter. Squarepoint Ops LLC purchased a new stake in shares of InnovAge during the fourth quarter worth $68,000. Finally, BNP Paribas Financial Markets acquired a new stake in shares of InnovAge in the fourth quarter valued at $123,000. 12.26% of the stock is currently owned by institutional investors and hedge funds.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.